NEWS & EVENTS
24th Sept 2014 The National Institute of Health and Care Excellence (NICE) has recommended self-monitoring of INR levels for people with atrial fibrillation and people with replacement heart valves - if the person prefers this form of testing and if the person or their carer is both physically and cognitively able to self-monitor effectively.
The National Institute for Health and Care Excellence (NICE) has revised its guidance on Atrial Fibrillation. It says that anticoagulation may be with Apixaban, Dabigatran Etixialte, Rivaroxaban or a Vitamin K Antagonist (warfarin). It also states that aspirin should no longer be used as a sole therapy for stroke prevention in AF.
Despite clear clinical guidelines, millions of patients with atrial fibrillation (AF) across Europe are not given the correct therapy – leaving them at serious risk of a debilitating and potentially fatal AF-related stroke. This is a worrying finding of a landmark report covering 27 European countries, which highlights the enormous and often hidden burden of AF and AF-related stroke in Europe.
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity
Access to the new anticoagulants: A joint statement from Anticoagulation Europe & Lifeblood: The Thrombosis Charity Lifeblood and Anticoagulation Europe are both very concerned that the NICE recommendations that there should be equal access to VKAs (warfarin) and NOACs in the NICE approved indications are not being implemented. The NHS constitution states that patients should not be denied access to NICE approved drugs.
ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.
CLICK ON WORDS ABOVE AND HELP US BY COMPLETING THE QUESTIONNAIRE Help develop national clinical guidance for the management of patients needing dental treatment and who are taking anticoagulant or antiplatelet drugs. What is the aim of this questionnaire? The aim of this questionnaire is to explore patients’: • Views of their experiences of dental treatment in primary care when taking anticoagulant drugs. • Concerns they may have that might be addressed by the new guidance.
Welcome to Anticoagulation Europe
The European Heart Rhythm Association needs your help with a short survey. Please spare the time to complete the survey.
The collection of this data is carried out anonymously.
The Scientific Initiative Committee (SIC), of the European Heart Rhythm Asssociation (EHRA) wants to find out about the level of information understood by patients treated with oral anticoagulants in the UK and the rest of Europe.
We rely on donations and subscriptions so please consider joining or making a donation to enable us to coninue our work.
You can donate by clicking on to the link to right of this page. For easy ways to help us raise funds, at no cost to you, click on Give as You Live at the bottom of the page.
AntiCoagulation Europe are raising free donations through easyfundraising.
If you’re shopping online then you could help, and it won’t cost you a penny!
Here’s how easy it is to do:
Just visit a retailer or Amazon via the easyfundraising website and any purchases you make will raise a free donation for us. It’s that simple!
They work with the leading retailers including Amazon, John Lewis, Argos and Marks and Spencer to name but a few.
It takes just a couple of minutes to register for free and no payment details are needed.
Please visit their page to find out more:
Sign our E-petition to get the government to debate free prescriptions for long term users of anticoagulation therapy
This petition replaces the first one which has expired. If you signed the first one you will need to sign again on this one. Please support us.